Profile
Andrew Bayliffe was the founder of Marengo Therapeutics, Inc., founded in 2021, where the title held was Chief Scientific Officer.
Dr. Bayliffe currently works at Apple Tree Venture Management Llc as a Venture Partner since 2019.
Dr. Bayliffe's education history includes a doctorate from the University of Leeds and an undergraduate degree from Manchester Metropolitan University, conferred in 1994.
Andrew Bayliffe active positions
| Companies | Position | Start |
|---|---|---|
Apple Tree Venture Management Llc//vc
Apple Tree Venture Management Llc//vc Investment ManagersFinance Apple Tree Partners invests in companies located in the United States. The firm focuses on the life sciences sector. It provides financing for seed, early and later stage capital requirements. | Private Equity Investor | 01/10/2019 |
Former positions of Andrew Bayliffe
| Companies | Position | End |
|---|---|---|
Marengo Therapeutics, Inc.
Marengo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunotherapies for cancer treatment | Founder | - |
Training of Andrew Bayliffe
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
University of Leeds
University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Manchester Metropolitan University
Manchester Metropolitan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Apple Tree Venture Management Llc//vc
Apple Tree Venture Management Llc//vc Investment ManagersFinance Apple Tree Partners invests in companies located in the United States. The firm focuses on the life sciences sector. It provides financing for seed, early and later stage capital requirements. | Finance |
Marengo Therapeutics, Inc.
Marengo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunotherapies for cancer treatment | Health Technology |
- Stock Market
- Insiders
- Andrew Bayliffe
















